BLESS (BLESS) fluctuated by 341.9% in 24 hours: Trading volume surge drives speculative pump
Bitget Pulse2026/04/14 02:28Volatility Overview
In the past 24 hours, the price of BLESS rebounded from a low of $0.0084458 (CMC data low of $0.008593) to a high of $0.0373221 (CMC high of $0.03677), currently quoted at $0.0215638, with a swing amplitude as high as 341.9%. The 24-hour trading volume surged to $98.5 million (according to CoinGecko, starting from $31.5 million), the market cap is approximately $37.94 million, and the volume/market cap ratio exceeds 200%, with a net capital inflow indicating a positive trend on CEX/DEX (around $5,000 net inflow).
Brief Analysis of the Cause of the Anomaly
- 24-hour trading volume soared by 361%, reaching $70–98 million, and the volume/mcap ratio exceeded 127%, triggering a low liquidity speculative pump.
- On-chain monitoring shows several whales buying in (e.g., six whales with large positions), with thin liquidity amplifying price fluctuations, but no large whale transfers recorded.
- No official announcements, listings, or partnership events; the price movement is mainly driven by market speculation and trading on BNB Chain DEXs such as PancakeSwap.
Market Views and Outlook
Community sentiment is bullish, with BLESS considered a Top Trending Coin on platform X. KOLs report “4x profit” and “whales entering,” supporting short-term bullishness (e.g., target price of $0.034). However, analysts note an RSI above 88 (overbought), with open interest at 29% long/71% short, raising concerns about a potential pullback to the $0.017 support level. It is recommended to wait for a retracement confirmation.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring and is for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
